Ouster stands out as the strongest LiDAR stock, with superior revenue, margins, cash position, and a bargain valuation at 4x revenue. Aeva, Luminar, and MicroVision remain strong sells, due to overvaluation, financial risk, and lack of meaningful revenue traction or differentiation. Innoviz's valuation is more reasonable, but the looming risk of a reverse split keeps me from upgrading it from sell to hold.
Here is how Aeva Technologies, Inc. (AEVA) and Bridgestone Corp. (BRDCY) have performed compared to their sector so far this year.
Aeva Technologies, Inc. (NASDAQ:AEVA ) Q1 2025 Earnings Conference Call May 14, 2025 5:00 PM ET Company Participants Andrew Fung - Senior Director of Investor Relations and Corporate Development Soroush Salehian - Chief Executive Officer Saurabh Sinha - Chief Financial Officer Conference Call Participants Colin Rusch - Oppenheimer & Company Joseph Moore - Morgan Stanley George Gianarikas - Canaccord Genuity Tyler Anderson - Craig-Hallum Capital Group LLC Suji Desilva - Roth Capital Operator Good day. My name is Jess, and I will be your conference facilitator.
Aeva Technologies, Inc. (AEVA) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.56 per share a year ago.
Aeva Technologies (AEVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aeva Technologies (AEVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here is how Aeva Technologies, Inc. (AEVA) and Michelin (MGDDY) have performed compared to their sector so far this year.
Aeva Technologies (AEVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Here is how Aeva Technologies, Inc. (AEVA) and Michelin (MGDDY) have performed compared to their sector so far this year.
With the latest round of tariffs from the Trump administration in early April 2025, investors and business owners alike are reckoning with the idea that the policy is encouraging a repatriation of manufacturing to the U.S. Should American firms that engage other countries to complete crucial manufacturing work offshore instead decide to build up manufacturing infrastructure domestically in order to avoid dealing with high tariffs on global imports, there will undoubtedly be a surge in demand for technologies and tools that make automation more readily achievable.
After struggling through a rough patch, the biotech industry seems to be staging a comeback.
Here is how Aeva Technologies, Inc. (AEVA) and Oshkosh (OSK) have performed compared to their sector so far this year.